Impaired immunomodulatory function of chronic myeloid leukemia cancer stem cells and the possible mechanism involved in it

Cancer Immunology, Immunotherapy

Volumn 62, Issue 4, 2013, Pages 689-703

  Xishan, Zhu ^a   Xinna, Zhou ^a   Baoxin, He ^a   Jun, Ren ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cells (CSCs); Chronic myeloid leukemia (CML); Hematopoietic stem cell (HSC); Immunological function; Matrix metalloproteinase 9 (MMP 9)

Indexed keywords

BCR ABL PROTEIN; CD31 ANTIGEN; CD34 ANTIGEN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN RECEPTOR 2;

ADOLESCENT; ADULT; ARTICLE; BCR ABL FUSION GENE; CANCER GROWTH; CANCER STEM CELL; CELL ISOLATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FUSION GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOMODULATION; LEUKEMOGENESIS; MALE; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ADOLESCENT; ADULT; APOPTOSIS; CASE-CONTROL STUDIES; CELL CYCLE; FEMALE; GENES, ABL; HUMANS; I-KAPPA B PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LYMPHOCYTE ACTIVATION; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASTIC STEM CELLS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD PROTEINS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; YOUNG ADULT;

EID: 84877812882     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1367-5     Document Type: Article

References (50)

1. Barnes DJ, Melo JV (2006) Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia. Cell Cycle 5:2862-2866
2. Jørgensen HG, Allan EK, Jordanides NE, Mountford JC, Holyoake TL (2007) Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells. Blood 109:4016-4019
3. Jørgensen HG, Copland M, Allan EK, Jiang X, Eaves A, Eaves C (2006) Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate. Clin Cancer Res 12:626-633
4. Ries C, Pitsch T, Mentele R, Zahler S, Egea V, Nagase H, Sede K (2007) Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1. Biochem J 405(3):547-558
5. Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 14:163-176
6. Fridman R, Toth M, Chvyrkova I, Meroueh S, Mobashery S (2003) Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 22:153-166
7. Stefanidakis M, Koivunen E (2006) Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood 108:1441-1450
8. Paupert J, Mansat-De Mas V, Demur C (2008) Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features. Cell Cycle 7(8):1047-1053 [Epub 2008 Jan 18]
9. Redondo-Muñoz J, José Terol M, García-Marco JA (2008) Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration Blood 111(1):383-386 [Epub 2007 Sept 21]
10. Redondo-Muñoz J, Escobar-Díaz E, Samaniego R (2006) MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration. Blood 108(9):3143-3151 [Epub 2006 Jul 13]
11. Shishodia S, Sethi G, Konopleva M, Andreeff M, Aggarwal BB (2006) A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells. Clin Cancer Res 12(6):1828-1838
12. Janowska-Wieczorek A, Majka M, Marquez-Curtis L, Wertheim JA, Turner AR, Ratajczak MZ (2002) Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia 16(6):1160-1166
13. Kaneta Y, Kagami Y, Tsunoda T, Ohno R, Nakamura Y, Katagiri T (2003) Genome-wide analysis of gene-expression profiles in chronic myeloid leukemia cells using a cDNA microarray. Int J Oncol 23(3):681-691
14. Bruchova H, Borovanova T, Klamova H, Brdicka R (2002) Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea. Leuk Lymphoma 43(6):1289-1295
15. Ries C, Loher F, Zang C, Ismair MG, Petrides PE (1999) Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Clin Cancer Res 5(5):1115-1124
16. Kim JG, Sohn SK, Kim DH, Baek JH, Lee NY, Suh JS, Chae SC, Lee KS, Lee KB (2005) Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leuk Lymphoma 46(6):885-891
17. Yoon S-O, Shin S, Lee H-J (2006) Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinosito 3 kinase/Akt dependent matrix metalloproteinase-9 expression. Mol Cancer Ther 5(11):344-349
18. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB (2008) Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 267(1):133-164
19. Fang B, Zheng C, Lianming L, Mingxia S, Shaoguang Y, Zhao RCH (2005) Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics. Blood 105(7):2733-2740
20. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM (2001) Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98:2615-2625
21. Guo H, Fang B, Zhao RC (2003) Hemangioblastic characteristics of fetal bone marrow-derived Flk1(+)CD31(-)CD34(-) cells. Exp Hematol 31:650-663
22. Lu Y, Wahl LM (2005) Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKK/NF- κB pathway. J Leukoc Biol 78(1):259-265
23. Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB (2004) Cell type-specific expression of the IκB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-κ B activation. J Biol Chem 279:1615-1620
24. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Lefde H (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436(7047):123-127
25. Karanes C, Nelson GO, Chitphakdithai P, Agura E, Ballen KK, Bolan CD, Wede N (2008) Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 14(9 Suppl):8-15
26. Martin MG, Dipersio JF, Uy GL (2008) Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors. Leuk Lymphoma. 29:1-10 [Epub ahead of print]
27. Martinelli G, Soverini S, Iacobucci I, Baccarani M (2009) Intermittent targeting as a tool to minimize toxicity of tyrosine kinase inhibitor therapy. Nat Clin Pract Oncol 6(2):68-69
28. Catriona H, Jamieson Y (2008) Chronic myeloid leukemia stem cell. Hematol Am Soc Hematol Educ Program 34:436-442
29. Pelletier SD, Hong DS, Hu Y, Sede J (2004) Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR/ABL-induced chronic myeloid leukemia-like myeloproliferative disease in mice. Blood 104:2163-2171
30. Martin-Henao GA, Quiroga R, Sureda A, Petes D (2000) L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression. Haematologica 85:139-146
31. Wertheim JA, Forsythe K, Druker BJ, Swede LH (2002) BCR-ABL-induced adhesion defects are tyrosine kinase-independent. Blood 99(11):4122-4130
32. Fiorel E, Fuscol C, Romero P (2002) Matrix metalloproteinase 9 (MMP-/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 21:5213-5223
33. Darai E, Stefanidakis M, Koivunen E (2006) Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood 108:1441-1450
34. Molica S, Vitelli G, Levato D, Giannarelli D, Vacca A, Cuneo A (2003) Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia. Eur J Haematol 10:373-378
35. Kamiguti AS, Lee ES, Till KJ, Harris RJ, Glenn MA, Lin K, Fedes KH (2004) The role of matrix metalloproteinase 9 in the pathogenesis of chronic lymphocytic leukaemia. Br J Haematol 125:128-140
36. Yue J, Mulder KM (2001) Transforming growth factor-h signal transduction in epithelial cells. Pharmacol Ther 91:1-34
37. Mucsi I, Skorecki KL, Goldberg HJ (1996) Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-h1 on gene expression. J Biol Chem 271:16567-16572
38. Munshi HG, Wu YI, Mukhopadyay S (2004) Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2 and p38 MAPK-modulated tissue inhibitor of metalloproteinase expression controls transforming growth factor-h1-induced pericellular collagenolysis. J Biol Chem 279:39042-39050
39. Kim ES, Kim MS, Moon A (2004) TGF-h-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 25:1375-1382
40. Horowitz JC, Lee DY, Waghray M (2004) Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-h1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem 279:1359-1367
41. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor b-medicated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803-36810
42. Kim WK, Hwang SY, Oh ES, Piao HZ, Kim KW, Han IO (2004) TGF-beta1 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity. J Immunol 172:7015-7023
43. Rahimi RA, Andrianifahanana M, Wilkes MC (2009) Distinct roles for mammalian target of rapamycin complexes in the fibroblast response to transforming growth factor-beta. Cancer Res 69(1):84-93
44. Assinder SJ, Dong Q, Mangs H (2009) Pharmacological targeting of the integrated AKT, PTEN and TGF-{beta} pathways in prostate cancer. Mol Pharmacol 75(3):429-436
45. Rexer BN, Engelman JA, Arteaga CL (2009) Overcoming resistance to tyrosine kinase inhibitors: Lessons learned from cancer cells treated with EGFR antagonists. Cell Cycle 8(1):18-22
46. Papakonstanti EA, Zwaenepoel O, Bilancio A, Burns E, Nock GE, Houseman B (2008) Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages. J Cell Sci 121(Pt 24):4124-4133 [Epub 2008 Nov 25]
47. Williams MR, Arthur JS, Balendran A, van der Kaay J, Poli V, Cohen P, Alessi DR (2000) The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol 10:439-448
48. Lu Y, Wahl LM (2005) Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKK/NF- κB pathway. J Leukoc Biol 78:259-265
49. Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB (2004) Cell type-specific expression of the IκB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-κB activation. J Biol Chem 279:1615-1620
50. Ben-Neriah Y (2002) Regulatory functions of ubiquitination in the immune system. Nat Immunol 3:20-26